For several years, I have geared my treatment of hyperlipidemia (Item 126-8) to a goal of 70 mg/dL LDL and 70 mg/dL triglycerides. In my treatment goals, I have placed great importance on the use of statins to (1) reduce endothelial dysfunction as manifest by reduction of cardiac-specific C-reactive protein and (2) enhance plaque regression. It’s not “just the numbers.”
—George L. Bradley, DO, Cherryville, N.C. (127-13)